Clinically Proven: LipoAvail® Boosts NAD+, VC & GSH

Overview


Effepharm

Only few liposomal brands can claim both animal and human clinical validation. While our clinically proven LipoAvail® liposomal series boosts bioavailability: NAD+ by 1.5×, VC by 1.65×, and GSH absorption by 1.38×.

NAD+ supports anti-ageing and metabolism. Our VC & GSH are boost for your skin’s radiance and antioxidant defense —they are all science-backed nutrition solution.

Liposomes encapsulate active ingredients, mimicking cell membranes for better absorption & efficacy.

Download the White Paper to find secrets of Liposomal technology, and discover more clinically backed LipoAvail® products.

This content is paid by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Latest Content

Related Resources

Uthever® NMN: Novel Food Approval Nearing Final Stage

Uthever® NMN: Novel Food Approval Nearing Final Stage

Paid for by Effepharm Ltd

White Paper

One Step Away from EU Market Compliance for NMN. The official positive opinion of Novel Food is expected to be published shortly, which means Uthever® NMN will be the first compliant ingredient.

Official: Uthever® NMN Secures FDA NDI Clearance

Official: Uthever® NMN Secures FDA NDI Clearance

Paid for by Effepharm Ltd

White Paper

Why choose Uthever®? Stronger compliance: Uthever® has secured an FDA NDI notification (NDI 1267), confirming the compliance of its NMN ingredient.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.